{"disease":{"id":"liver-transplant-rejection","name":"Liver transplant rejection","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"cyclosporine","indication_name":"Prevention of Liver Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sandimmune","generic_name":"cyclosporine","company_name":"Novartis AG (originally Sandoz)","drug_phase":"marketed","molecular_target":"Calcineurin subunit B type 1, Canalicular multispecific organic anion transporter 1, Canalicular multispecific organic anion transporter 2","drug_class":"Calcineurin inhibitor (immunosuppressant)","quality_score":67,"revenue":"1866.0","mechanism":"Calcineurin inhibitor that suppresses T-cell activation by blocking IL-2 transcription, preventing organ transplant rejection."},{"drug_id":"ciclosporin","indication_name":"Prevention of Liver Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Sandimmune","generic_name":"Ciclosporin","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform","drug_class":"Calcineurin Inhibitor Immunosuppressant [EPC]","quality_score":68,"revenue":"1866.0","mechanism":""},{"drug_id":"tacrolimus","indication_name":"Liver transplant rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prograf","generic_name":"TACROLIMUS","company_name":"Astellas Pharma","drug_phase":"marketed","molecular_target":"Interferon gamma","drug_class":"Calcineurin Inhibitor Immunosuppressant","quality_score":80,"revenue":"1600","mechanism":"Prograf works by inhibiting the activation of T-lymphocytes, a type of immune cell."},{"drug_id":"tacrolimus","indication_name":"Prevention of Liver Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Prograf","generic_name":"TACROLIMUS","company_name":"Astellas Pharma","drug_phase":"marketed","molecular_target":"Interferon gamma","drug_class":"Calcineurin Inhibitor Immunosuppressant","quality_score":80,"revenue":"1600","mechanism":"Prograf works by inhibiting the activation of T-lymphocytes, a type of immune cell."},{"drug_id":"mycophenolic-acid","indication_name":"Prevention of Liver Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mycophenolate","generic_name":"MYCOPHENOLIC ACID","company_name":"Novartis","drug_phase":"marketed","molecular_target":"Inosine-5'-monophosphate dehydrogenase 2","drug_class":"Antimetabolite Immunosuppressant","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"neoral","indication_name":"Prevention of Liver Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Neoral","company_name":"Novartis Pharmaceuticals","drug_phase":"marketed","molecular_target":"Calcineurin subunit B type 1, Canalicular multispecific organic anion transporter 1, Canalicular multispecific organic anion transporter 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"cyclosporin","indication_name":"Prevention of Liver Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cyclosporin","company_name":"Karolinska University Hospital","drug_phase":"marketed","molecular_target":"Calcineurin subunit B type 1, Canalicular multispecific organic anion transporter 1, Canalicular multispecific organic anion transporter 2","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"mycophenolate","indication_name":"Prevention of Liver Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Mycophenolate","company_name":"Sanofi","drug_phase":"marketed","molecular_target":"Inosine-5'-monophosphate dehydrogenase 1, Inosine-5'-monophosphate dehydrogenase 2, Inosine-5'-monophosphate dehydrogenase (IMPDH)","drug_class":"","quality_score":42,"revenue":null,"mechanism":null},{"drug_id":"ciclosporine","indication_name":"Prevention of Liver Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ciclosporine","company_name":"Hospices Civils de Lyon","drug_phase":"phase_3","molecular_target":"Calcineurin subunit B type 1, Canalicular multispecific organic anion transporter 1, Canalicular multispecific organic anion transporter 2","drug_class":"","quality_score":35,"revenue":null,"mechanism":null},{"drug_id":"mycophenolate-mofetil","indication_name":"Prevention of Liver Transplant Rejection","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cellcept","generic_name":"MYCOPHENOLATE MOFETIL","company_name":"Roche Palo","drug_phase":"marketed","molecular_target":"Inosine-5'-monophosphate dehydrogenase 2","drug_class":"Antimetabolite Immunosuppressant","quality_score":10,"revenue":null,"mechanism":"Cellcept works by inhibiting the enzyme inosine-5'-monophosphate dehydrogenase 2, which is necessary for the production of guanosine nucleotides."}],"pipeline":[],"offLabel":[],"totalMarketed":10,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04694573","title":"Multicenter CTS Pre-and Post-Transplantation Covid-19 Serum Studies","phase":"","overall_status":"UNKNOWN","enrollment_count":600,"lead_sponsor_name":"Heidelberg University","has_results":false},{"nct_id":"NCT05707520","title":"Long-term Benefit of MPA in Liver Transplantation","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Third Affiliated Hospital, Sun Yat-Sen University","has_results":false},{"nct_id":"NCT04234139","title":"Cohort/Ethics Study of Patients With Severe Alcoholic Hepatitis Undergoing Early Liver Transplantation","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":300,"lead_sponsor_name":"Johns Hopkins University","has_results":false},{"nct_id":"NCT03603548","title":"Comparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) in Patients After Liver Transplantation : Single Center Randomised Control Trial","phase":"NA","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Medical University of Warsaw","has_results":false},{"nct_id":"NCT06103097","title":"Histologic Evolution of Patients With Liver Transplantation","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"Hospital Vall d'Hebron","has_results":false},{"nct_id":"NCT03815864","title":"Antibodies and Liver Retransplantation","phase":"","overall_status":"UNKNOWN","enrollment_count":200,"lead_sponsor_name":"London Health Sciences Centre","has_results":false},{"nct_id":"NCT03781414","title":"Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":129,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT06060808","title":"Role of NFKBIA and PTPN22 Genes Polymorphism in Acute Rejection Susceptibility After Living Donor Liver Transplantation in Egyptian Patients.","phase":"","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Helwan University","has_results":false},{"nct_id":"NCT04514666","title":"VOCs in Kidney and Liver Transplants","phase":"NA","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Societa Italiana di Chirurgia ColoRettale","has_results":false},{"nct_id":"NCT07053488","title":"CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection","phase":"PHASE1, PHASE2","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC","has_results":false},{"nct_id":"NCT06153641","title":"Cytokeratin 18 Non-invasive Biomarker for Rejection in Liver Transplant Patients","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":70,"lead_sponsor_name":"St. Louis University","has_results":false},{"nct_id":"NCT03874286","title":"The TOGETHER Project - Liver","phase":"","overall_status":"COMPLETED","enrollment_count":54,"lead_sponsor_name":"Mayo Clinic","has_results":false},{"nct_id":"NCT05655273","title":"Conversion of Maintenance Prograf to Envarsus in Liver Transplant Recipients","phase":"PHASE4","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":40,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT04789213","title":"Mortality, Morbidity and Risk Factors of Liver Retransplantation","phase":"","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Memorial Bahçelievler Hospital","has_results":false},{"nct_id":"NCT06400771","title":"Safety of DNP007 in Healthy Subjects","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Seoul National University Hospital","has_results":false},{"nct_id":"NCT05325073","title":"Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":9,"lead_sponsor_name":"Northwestern University","has_results":false}],"total":16},"guidelines":[],"source":"Drug Landscape verified database"}